Actos Cancer Guide

In 2015, Takeda Pharmaceuticals agreed to a massive $2.37 billion settlement to resolve approximately 9,000 bladder cancer claims in the U.S..

Studies indicated that the risk increased with higher cumulative doses and longer duration of use (specifically more than 12 months). ACTOS CANCER

, such as needing to urinate more frequently or urgently. Pain during urination (dysuria). Pain in the lower back or pelvic region . 4. Legal Status and Claims In 2015, Takeda Pharmaceuticals agreed to a massive $2